This analysis of data from an open-label, nonrandomized, multicohort study of patients from the VE-BASKET trial evaluates the efficacy and safety of vemurafenib in the treatment of adults with BRAF V600–mutant Erdheim-Chester disease or Langerhans cell histiocytosis.
http://ift.tt/2AIb9Aw
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
-
Publication date: Available online 22 March 2017 Source: Vaccine Author(s): Yanli Yang, Qizu Zhao, Zhengjun Li, Lijing Sun, Guanghui Ma,...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου